FailSafe A Delaware Corporation
How it works Sourcing Populations Founder
Whitepaper Request info
Controlled-access packaging • Safety between doses

Access control, built into the cap.

FailSafe is a packaging-level, controlled-access safety cap designed to restrict physical access to prescription medications between scheduled dosing windows—helping reduce misuse, diversion, accidental pediatric exposure, and unsafe access in vulnerable settings.

Prototype image shown. Early-stage venture exploring pilots and pharmaceutical partners.
FailSafe controlled-access safety cap prototype
FailSafe prototype

How it works

A familiar pharmacy-cap experience—passive, discreet, and protective.

Unlocks at scheduled intervals

Access is permitted only during an authorized dosing window—reducing early or duplicate dosing.

Automatically re-locks

Between doses, the cap returns to a locked state, reducing repeated access and diversion risk.

No app required

No screens, pairing, or surveillance—packaging-level safety designed to “just work.”

Sourced through pharmaceutical partners

FailSafe is designed to be supplied through pharmaceutical manufacturers by integrating into existing packaging workflows—positioning controlled access as primary drug packaging, not an after-market add-on.

Deployment model

  • Manufacturer integration: designed for packaging-line sourcing and scale.
  • Primary packaging: compatible with standard bottle formats and pharmacy workflows.
  • Controlled-substance alignment: targeted for risk mitigation where access matters most.

Why packaging-level safety

  • Addresses unrestricted physical access once medication enters the home.
  • Complements education and monitoring by adding a physical safeguard.
  • Preserves autonomy with a familiar cap experience.

Target populations

FailSafe is designed for settings where safety, autonomy, and access control matter—without adding friction, apps, or surveillance.

Veterans & active-duty military

  • Non-punitive safeguard for scheduled access in high-stress environments.
  • Helps reduce early/duplicate dosing without behavior-dependent systems.
  • Reduces diversion risk in shared living spaces.

Pediatric safety

  • Adds protection between doses beyond child-resistant closures.
  • Reduces accidental ingestion risk without relying on vigilance alone.

Alzheimer’s & dementia

  • Passive access control that can support independence longer.
  • Helps reduce unsafe access outside authorized windows.

Controlled-substance risk mitigation

  • Targets diversion and impulsive overuse at the access level.
  • Designed to complement existing prescribing and safety workflows.

Meet the Founder

Building packaging-level safety informed by population-level evidence.

Nima Ogabian, Founder of FailSafe

Nima Ogabian

Founder of FailSafe. Focused on reducing medication-related harm by addressing post-dispensing access failures through evidence-informed pharmaceutical packaging design.

Technical whitepaper

A detailed, evidence-informed analysis of post-dispensing medication risk and the design rationale for packaging-level access control.

Read the whitepaper (PDF)

Interested in pilots or partnerships?

Reach out for a short overview, packaging integration discussion, or pilot planning.

Contact FailSafe Whitepaper Back to top